Klein J C, Beems R B, Zwart P E, Hamzink M, Zomer G, van Steeg H, van Kreijl C F
Laboratory of Health Effects Research, National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven,The Netherlands.
Carcinogenesis. 2001 Apr;22(4):619-26. doi: 10.1093/carcin/22.4.619.
The effects of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) were studied in DNA repair deficient XPA(-/-) mice. The nullizygous XPA-knockout mice, which lack a functional nucleotide excision repair (NER) pathway, were exposed to dietary concentrations ranging from 10 to 200 p.p.m. The results show that PhIP is extremely toxic to XPA(-/-) mice, even at doses 10-fold lower than tolerated by wild-type C57BL/6 mice. XPA(-/-) mice rapidly lost weight and died within 2 and 6 weeks upon administration of 200 and 100 p.p.m., respectively. Intestinal abnormalities like distended and overfilled ileum and caecum, together with clear signs of starvation, suggests that the small intestines were the primary target tissue for the severe toxic effects. Mutation analysis in XPA(-/-) mice carrying a lacZ reporter gene, indicated that the observed toxicity of PhIP might be caused by genotoxic effects in the small intestine. LacZ mutant frequencies appeared to be selectively and dose-dependently increased in the intestinal DNA of treated XPA(-/-) mice. Furthermore, DNA repair deficient XPC(-/-) mice, which are still able to repair DNA damage in actively transcribed genes, did not display any toxicity upon treatment with PhIP (100 p.p.m.). This suggests that transcription coupled repair of DNA damage (PhIP adducts) in active genes plays a crucial role in preventing the intestinal toxicity of PhIP. Finally, PhIP appeared to be carcinogenic for XPA(-/-) mice at subtoxic doses. Upon treatment of the mice for 6 months with 10 or 25 p.p.m. PhIP, significantly increased tumour incidences were observed after a total observation period of one year. At 10 p.p.m. only lymphomas were found, whereas at 25 p.p.m. some intestinal tumours (adenomas and adenocarcinomas) were also observed.
在DNA修复缺陷的XPA(-/-)小鼠中研究了食品诱变剂2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)的作用。纯合XPA基因敲除小鼠缺乏功能性核苷酸切除修复(NER)途径,使其暴露于浓度范围为10至200 ppm的膳食中。结果表明,即使剂量比野生型C57BL/6小鼠耐受剂量低10倍,PhIP对XPA(-/-)小鼠也具有极高毒性。给予200 ppm和100 ppm的PhIP后,XPA(-/-)小鼠体重迅速减轻,分别在2周和6周内死亡。肠道异常,如回肠和盲肠扩张及充盈过度,以及明显的饥饿迹象,表明小肠是严重毒性作用的主要靶组织。对携带lacZ报告基因的XPA(-/-)小鼠进行的突变分析表明,观察到的PhIP毒性可能是由小肠中的基因毒性作用引起的。在用PhIP处理的XPA(-/-)小鼠的肠道DNA中,LacZ突变频率似乎有选择性地且呈剂量依赖性增加。此外,DNA修复缺陷的XPC(-/-)小鼠仍能够修复活跃转录基因中的DNA损伤,在用PhIP(100 ppm)处理后未表现出任何毒性。这表明活跃基因中DNA损伤(PhIP加合物)的转录偶联修复在预防PhIP的肠道毒性中起关键作用。最后,在亚毒性剂量下,PhIP对XPA(-/-)小鼠似乎具有致癌性。在用10或25 ppm的PhIP处理小鼠6个月后,在一年的总观察期后观察到肿瘤发生率显著增加。在10 ppm时仅发现淋巴瘤,而在25 ppm时还观察到一些肠道肿瘤(腺瘤和腺癌)。